Ephedra

Rhino Rush Energy Fuels Formula DRIFT Star Matt Field's Championship Dreams

Retrieved on: 
Tuesday, April 2, 2024
Matt Field, Partnership, Social media, Ephedra, Field, Nootropic, Aggressive driving, CMO, Formula D, Hunting

BOISE, Idaho, April 2, 2024 /PRNewswire/ -- Rhino Rush Energy , a leading name in energy shots, is thrilled to announce its latest high-octane partnership with Formula DRIFT sensation, Matt Field, for the 2024 season.

Key Points: 
  • BOISE, Idaho, April 2, 2024 /PRNewswire/ -- Rhino Rush Energy , a leading name in energy shots, is thrilled to announce its latest high-octane partnership with Formula DRIFT sensation, Matt Field, for the 2024 season.
  • "I'm thrilled to join forces with Rhino Rush for the 2024 Formula Drift season," added Matt Field.
  • As the Formula Drift season revs into high gear, fans of Matt Field and Rhino Rush can look forward to an electrifying partnership that promises to bring even more excitement and energy to the sport.
  • Stay tuned for updates and follow both Matt Field and Rhino Rush on social media for behind-the-scenes content, race day highlights, and more.

FLINT COOPER HIRES NATIONALLY RECOGNIZED LEADER TRENT MIRACLE AS PARTNER TO LEAD ITS MASS TORTS PRACTICE

Retrieved on: 
Wednesday, September 20, 2023
Justice, Asbestos, Professional, Miracle, String interpolation, AAJ, Bayer, AbbVie, American Association for Justice, Johnson & Johnson, DePuy Synthes, Ephedra, Rofecoxib, Pharmaceutical industry, Merck

EDWARDSVILLE, Ill., Sept. 20, 2023 /PRNewswire/ -- Flint Cooper is pleased to announce that Trent Miracle has joined the firm.

Key Points: 
  • EDWARDSVILLE, Ill., Sept. 20, 2023 /PRNewswire/ -- Flint Cooper is pleased to announce that Trent Miracle has joined the firm.
  • Miracle will serve as the managing member of the firm's mass torts practice.
  • At Flint Cooper, Miracle and his experienced team of professionals will litigate the firm's mass tort cases, as well as manage the strategic direction of the practice.
  • He is an experienced litigator in high-profile cases and will be taking our mass torts practice to the next level," said Ethan Flint, co-managing member of Flint Cooper.

Ozempic is in the spotlight but it's just the latest in a long and strange history of weight-loss drugs

Retrieved on: 
Tuesday, August 8, 2023
Exercise, Injection, Seizure, Amgen, Letter, Endocrinology, Human, Food, Obesity, Industry, Diet, US Food Sovereignty Alliance, Diabetes, Ephedra, Leptin, Stroke, Phentermine, Splenic infarction, Hope, Psychotherapy, Research, Appetite, History, Diarrhea, Due, Sale, Movement, Hormone, Science, Athlete, US, Dietary supplement, Patient, Time, Poisoning, Amphetamine, Novo Nordisk, Overweight, Hypothalamus, Pleasure, Fenfluramine, Nausea, Mouse, Growth, Knowledge, Health, Death, Safety, Social environment, Social media, Cosmetics, Canning, Birth control, Pharmaceutical industry, Drug, Nightclub, Semaglutide

That’s been the holy grail of weight-loss ever since 19th century English undertaker and weight-loss celebrity William Banting’s 1863 Letter on Corpulence spruiked his “miraculous” method of slimming down.

Key Points: 
  • That’s been the holy grail of weight-loss ever since 19th century English undertaker and weight-loss celebrity William Banting’s 1863 Letter on Corpulence spruiked his “miraculous” method of slimming down.
  • Since then, humans have tried many things – diet, exercise, psychotherapy, surgery – to lose weight.
  • But time and again we return to the promise of a weight-loss drug, whether it’s a pill, injection, or tonic.

Ozempic is a recent arrival

    • Ozempic and its sister drug Wegovy, both manufactured by Novo Nordisk, are the latest offerings in a long history of drug treatments for people who are overweight.
    • This has helped drive a shortage of Ozempic for diabetes treatment.

From ‘gland treatment’ to amphetamines

    • For example, organotherapy (gland treatment) was hugely popular in the 1920s to 1940s.
    • Doctors prescribed overweight people extracts of animal glands – either eaten raw or dried in pill form or injected – to treat their supposedly “sluggish glands”.
    • Amphetamines were first used as a nasal decongestant in the 1930s, but quickly found a market for weight-loss.
    • Amphetamines too, fell from treatment use in the 1970s with Nixon’s “war on drugs” and recognition they were addictive.

Another decade, another drug

    • For example, the popular diet drug of the 1980s and 90s was fen-phen, which contained appetite suppressants fenfluramine and phentermine.
    • And as history recognises, multiple complexities can combine to push a drug into popularity or damn it to history’s rubbish bin.
    • One noticeable contrast with past diet drug experiences is that now, many people are happy to talk about using Ozempic.
    • It seems to be increasingly socially acceptable to use a drug to achieve weight-loss for primarily aesthetic reasons.

Our enduring search for weight-loss drugs

    • Ozempic is predicted to earn Novo Nordisk US$12.5 billion this year alone, but it’s not just industry interests stoking this enduring desire for weight-loss drugs.
    • Patients on an endless cycle of dieting and exercise want something more convenient, with a more certain outcome.
    • It is no wonder demand for weight-loss drugs continues to soar.

Emerging methamphetamine industry in Afghanistan ‘worrying’, says new EMCDDA study

Retrieved on: 
Tuesday, November 24, 2020
Psychoactive drugs, Drugs, Stimulants, Euphoriants, Substituted amphetamines, TAAR1 agonists, Dietary Supplements, Ephedrine, Methamphetamine, Ephedra, MDMA, Bakwa District

Lisbon 

Key Points: 


Lisbon 
24.11.2020(News release No11/2020)

  • There are signs that a methamphetamine industry is taking hold in Afghanistan, according to a new report published today by the EU drugs agency (EMCDDA).
  • The paper Emerging evidence of Afghanistans role as a producer and supplier of ephedrine and methamphetamine explores whether the country, renowned for being the world's leading opium producer, has the potential to become a significant producer of methamphetamine.
  • The study is based on interviews with ephedrine and methamphetamine cooks, and other key informants, in the district of Bakwa (Farah province, south-west Afghanistan) in August 2020, as well as on documentary sources and the analysis of high-resolution satellite images.
  • Once produced, the ephedrine is sold to traders from other provinces or directly to local methamphetamine production facilities, where skilled methamphetamine cooks take over.
  • There are also increasing reports of methamphetamine connected with Afghanistan being seized further afield (e.g.
  • If the potential amount of ephedrine produced in Bakwa were converted into methamphetamine locally, the industry could be worth an estimated EUR 203 million in Bakwa alone.
  • Increasing reports of further ephedrine and methamphetamine processing in other Afghan provinces (Nimroz, Herat, Nangarhar), raises concern that the output of the countrys methamphetamine industry could one day potentially rival its sizeable opiate economy.
  • The report notes that there is considerable scope for ephedra crop cultivation in Afghanistan.


(1) Ephedrine is one of the precursor chemicals used to make methamphetamine. For more on other methamphetamine precursors, see the EMCDDA Methamphetamine drug profile.

Emerging evidence of Afghanistan’s role as a producer and supplier of ephedrine and methamphetamine

Retrieved on: 
Tuesday, November 24, 2020
Drugs, Psychoactive drugs, Branches of biology, Dietary Supplements, Stimulants, Ephedra, Afghanistan, European Monitoring Centre for Drugs and Drug Addiction, Methamphetamine

EMCDDA, David Mansfield (lead author), Lisbon, November 2020

Key Points: 
  • EMCDDA, David Mansfield (lead author), Lisbon, November 2020
    This paper provides an analysis of the available data that suggest that a methamphetamine industry is rapidly being established in Afghanistan.
  • The analysis provided is based on information from key informants, documentary sources and the analysis of satellite imagery.
  • The paper also highlights an expanding market for ephedra that links the mountainous central region of Afghanistan to the former deserts of the south-west.
  • The report is the result of research conducted under the EU4Monitoring Drugs (EU4MD) project, funded by the European Commission.